U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07737847) titled 'Clinical Study on ShouTai Pills for Improving Reduced Ovarian Reserve' on July 20.
Brief Summary: Grounded in the 'disease-syndrome combination' paradigm, this study endeavors to address the pivotal scientific issues pertaining to the clinical precision of Traditional Chinese Medicine (TCM) in managing Diminished Ovarian Reserve (DOR) classified as the Kidney Essence Deficiency type, through the application of systems biology technologies, including metabolomics.
Study Start Date: Oct. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Diminished Ovarian Reserve (DOR)
Intervention:
DRUG: Shoutai Pill
The experimental group took S...